- Home
- Publications
- Publication Search
- Publication Details
Title
Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-03
DOI
10.3389/fnins.2021.614251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
- (2020) Shin‐Ichi Ueno et al. Annals of Clinical and Translational Neurology
- Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease
- (2020) Mihai S. Cirstea et al. MOVEMENT DISORDERS
- Early Onset of Sex-Dependent Mitochondrial Deficits in the Cortex of 3xTg Alzheimer’s Mice
- (2020) Jelena Djordjevic et al. Cells
- Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
- (2020) Zachary D. Wallen et al. npj Parkinsons Disease
- GBA Variants in Parkinson's Disease: Clinical, Metabolomic, and Multimodal Neuroimaging Phenotypes
- (2020) Andrea Greuel et al. MOVEMENT DISORDERS
- Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
- (2020) Sarah Vascellari et al. mSystems
- Developmental Changes in Dendritic Spine Morphology in the Striatum and Their Alteration in an A53T α-Synuclein Transgenic Mouse Model of Parkinson’s Disease
- (2020) Laxmi Kumar Parajuli et al. eNeuro
- Metabolomics-based identification of metabolic alterations in PARK2
- (2019) Ayami Okuzumi et al. Annals of Clinical and Translational Neurology
- Benefits of Vitamins in the Treatment of Parkinson’s Disease
- (2019) Xiuzhen Zhao et al. Oxidative Medicine and Cellular Longevity
- Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity
- (2019) Stefano Thellung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modification of the gut microbiome to combat neurodegeneration
- (2019) Andrew Octavian Sasmita REVIEWS IN THE NEUROSCIENCES
- Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats
- (2019) Nathalie Van Den Berge et al. ACTA NEUROPATHOLOGICA
- A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study
- (2019) Jacopo Troisi et al. Metabolomics
- Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1−/− mice
- (2019) Diana Matheoud et al. NATURE
- Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
- (2019) Sangjune Kim et al. NEURON
- Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort
- (2019) García D. Santos et al. PARKINSONISM & RELATED DISORDERS
- A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body–like pathology
- (2019) Juan A. Gerez et al. Science Translational Medicine
- Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging of Lipids in Experimental Model of Traumatic Brain Injury Detecting Acylcarnitines as Injury Related Markers
- (2019) Khalil Mallah et al. ANALYTICAL CHEMISTRY
- Gut microbes, ageing & organ function: a chameleon in modern biology?
- (2019) Musarrat Maisha Reza et al. EMBO Molecular Medicine
- Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
- (2019) Heather Wilson et al. LANCET NEUROLOGY
- Ageing as a risk factor for neurodegenerative disease
- (2019) Yujun Hou et al. Nature Reviews Neurology
- Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies
- (2019) Lingyun Xu et al. PLoS One
- Prion-Like Mechanisms in Parkinson’s Disease
- (2019) Jiangnan Ma et al. Frontiers in Neuroscience
- Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
- (2019) Ingrid González-Casacuberta et al. Frontiers in Neuroscience
- Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health
- (2019) Aimée Parker et al. Gut Microbes
- Metabolomic analysis revealed mitochondrial dysfunction and aberrant choline metabolism in MPP+-exposed SH-SY5Y cells
- (2019) Taku Amo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Antibiotic exposure and risk of Parkinson's disease in Finland: A nationwide case‐control study
- (2019) Tuomas H. Mertsalmi et al. MOVEMENT DISORDERS
- Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients
- (2019) Sarah Louise Nickels et al. PARKINSONISM & RELATED DISORDERS
- Faecal Transplantation, Pro- and Prebiotics in Parkinson’s Disease; Hope or Hype?
- (2019) T. Van Laar et al. Journal of Parkinsons Disease
- The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation
- (2019) Eun-Jin Bae et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Sodium butyrate causes α-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway
- (2019) Chen-Meng Qiao et al. EXPERIMENTAL CELL RESEARCH
- Flavonoid metabolism: the interaction of metabolites and gut microbiota
- (2018) Kaeko Murota et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Human gut microbiome: hopes, threats and promises
- (2018) Patrice D Cani GUT
- Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson’s Disease Reveals Distinct Metabolic Profiles
- (2018) Stewart F. Graham et al. JOURNAL OF PROTEOME RESEARCH
- Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
- (2018) Kuo-Hsuan Chang et al. MOLECULAR NEUROBIOLOGY
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
- (2018) Emily M. Rocha et al. NEUROBIOLOGY OF DISEASE
- Association of metals with the risk and clinical characteristics of Parkinson's disease
- (2018) Mi-Jung Kim et al. PARKINSONISM & RELATED DISORDERS
- Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s disease
- (2018) Diego Grassi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Parkin function in Parkinson's disease
- (2018) Connor Arkinson et al. SCIENCE
- Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease
- (2018) Daniel Stoessel et al. Frontiers in Aging Neuroscience
- Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function
- (2018) Ana Agustí et al. Frontiers in Neuroscience
- Serotonergic dysregulation is linked to sleep problems in Parkinson's disease
- (2018) Heather Wilson et al. NeuroImage-Clinical
- Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
- (2018) Barry Boland et al. NATURE REVIEWS DRUG DISCOVERY
- Gut microbiota in patients with Parkinson's disease in southern China
- (2018) Aiqun Lin et al. PARKINSONISM & RELATED DISORDERS
- Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression
- (2018) Mei-Xue Dong et al. Frontiers in Molecular Neuroscience
- Polychromatic Light Exposure as a Therapeutic in the Treatment and Management of Parkinson's Disease: A Controlled Exploratory Trial
- (2018) Gregory L. Willis et al. Frontiers in Neurology
- Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) E. Ray Dorsey et al. LANCET NEUROLOGY
- 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease
- (2018) Christos Koros et al. MOVEMENT DISORDERS
- Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
- (2018) Desiree Willkommen et al. PLoS One
- GBA Analysis in Next-Generation Era
- (2017) Stefania Zampieri et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- An overview of renal metabolomics
- (2017) Sahir Kalim et al. KIDNEY INTERNATIONAL
- Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies
- (2017) Daryl J Wile et al. LANCET NEUROLOGY
- Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2017) Valery L Feigin et al. LANCET NEUROLOGY
- Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
- (2017) Jean-Pierre Trezzi et al. MOVEMENT DISORDERS
- Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features
- (2017) Jennifer G. Goldman et al. MOVEMENT DISORDERS
- Serum uric acid levels and freezing of gait in Parkinson’s disease
- (2017) Ruwei Ou et al. NEUROLOGICAL SCIENCES
- Genetic Forms of Parkinson's Disease
- (2017) Christine Kim et al. SEMINARS IN NEUROLOGY
- Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
- (2017) David A. Loeffler et al. Frontiers in Aging Neuroscience
- Oxidative stress and cellular pathologies in Parkinson’s disease
- (2017) Lesly Puspita et al. Molecular Brain
- Circulating microRNAs as Potential Biomarkers of Infectious Disease
- (2017) Carolina N. Correia et al. Frontiers in Immunology
- Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
- (2017) Shinji Saiki et al. Scientific Reports
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Parkinson's disease: Autoimmunity and neuroinflammation
- (2016) Armando De Virgilio et al. AUTOIMMUNITY REVIEWS
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
- (2016) Diana Matheoud et al. CELL
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
- (2016) Annika Wahlström et al. Cell Metabolism
- The relationship between glucocerebrosidase mutations and Parkinson disease
- (2016) Anna Migdalska-Richards et al. JOURNAL OF NEUROCHEMISTRY
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance
- (2016) Dena G. Hernandez et al. JOURNAL OF NEUROCHEMISTRY
- Neuroendocrine abnormalities in Parkinson's disease
- (2016) Eduardo De Pablo-Fernández et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
- (2016) Marcus D Tuttle et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Biomarkers in Parkinson's disease: Advances and strategies
- (2016) Marion Delenclos et al. PARKINSONISM & RELATED DISORDERS
- Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts
- (2016) Giambattista Guaitoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II-mediated respiration
- (2016) Kelly L. Stauch et al. Proteomics Clinical Applications
- α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
- (2016) Roberto Di Maio et al. Science Translational Medicine
- Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein
- (2016) Marcus D Tuttle et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Enhancing NAD+salvage metabolism is neuroprotective in a PINK1 model of Parkinson's disease
- (2016) Susann Lehmann et al. Biology Open
- Transient and Prolonged Response of Chicken Cecum Mucosa to Colonization with Different Gut Microbiota
- (2016) Jiri Volf et al. PLoS One
- Clinical correlates of raphe serotonergic dysfunction in early Parkinson’s disease
- (2015) Zahi Qamhawi et al. BRAIN
- LC/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: Implication for mitochondrial dysfunction in Parkinson's disease
- (2015) Y. Y. Tyurina et al. FREE RADICAL RESEARCH
- Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
- (2015) Taku Hatano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Colonic bacterial composition in Parkinson's disease
- (2015) Ali Keshavarzian et al. MOVEMENT DISORDERS
- Identification of candidate genes for Parkinson's disease through blood transcriptome analysis in LRRK2-G2019S carriers, idiopathic cases, and controls
- (2015) Jon Infante et al. NEUROBIOLOGY OF AGING
- The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
- (2015) Alicia M. Pickrell et al. NEURON
- The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments
- (2015) V. Sanchez-Guajardo et al. NEUROSCIENCE
- Helicobacter pylori infection is associated with worse severity of Parkinson's disease
- (2015) Ai Huey Tan et al. PARKINSONISM & RELATED DISORDERS
- Global Metabolomic Identification of Long-Term Dose-Dependent Urinary Biomarkers in Nonhuman Primates Exposed to Ionizing Radiation
- (2015) Evan L. Pannkuk et al. RADIATION RESEARCH
- Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson’s disease
- (2015) Hemi Luan et al. Scientific Reports
- Viable Neuronopathic Gaucher Disease Model in Medaka (Oryzias latipes) Displays Axonal Accumulation of Alpha-Synuclein
- (2015) Norihito Uemura et al. PLoS Genetics
- Longitudinal Metabolomics Profiling of Parkinson’s Disease-Related α-Synuclein A53T Transgenic Mice
- (2015) Xi Chen et al. PLoS One
- Alterations in Energy/Redox Metabolism Induced by Mitochondrial and Environmental Toxins: A Specific Role for Glucose-6-Phosphate-Dehydrogenase and the Pentose Phosphate Pathway in Paraquat Toxicity
- (2014) Shulei Lei et al. ACS Chemical Biology
- Orally delivered water soluble Coenzyme Q10 (Ubisol-Q10) blocks on-going neurodegeneration in rats exposed to paraquat: potential for therapeutic application in Parkinson’s disease
- (2014) Krithika Muthukumaran et al. BMC NEUROSCIENCE
- Lys-63-linked Ubiquitination by E3 Ubiquitin Ligase Nedd4-1 Facilitates Endosomal Sequestration of Internalized α-Synuclein
- (2014) Naoto Sugeno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In Vivo
- (2014) Brian Spencer et al. MOLECULAR THERAPY
- Gut microbiota are related to Parkinson's disease and clinical phenotype
- (2014) Filip Scheperjans et al. MOVEMENT DISORDERS
- Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson’s disease
- (2014) Roberta Tufi et al. NATURE CELL BIOLOGY
- Polyunsaturated fatty acids and their metabolites in brain function and disease
- (2014) Richard P. Bazinet et al. NATURE REVIEWS NEUROSCIENCE
- Mitochondrial Enhancement for Neurodegenerative Movement Disorders: A Systematic Review of Trials Involving Creatine, Coenzyme Q10, Idebenone and Mitoquinone
- (2013) Jia Liu et al. CNS DRUGS
- The metabolomics of alpha-synuclein (SNCA) gene deletion and mutation in mouse brain
- (2013) Ruth E. Musgrove et al. Metabolomics
- The genetics of Parkinson's disease: Progress and therapeutic implications
- (2013) Andrew B. Singleton et al. MOVEMENT DISORDERS
- 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- The role of small intestinal bacterial overgrowth in Parkinson's disease
- (2013) Alfonso Fasano et al. MOVEMENT DISORDERS
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
- (2013) Robert A Koeth et al. NATURE MEDICINE
- Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
- (2013) Laura Dunn et al. NEUROBIOLOGY OF AGING
- Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson’s Disease: a Pilot Study
- (2013) James R. Roede et al. PLoS One
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- The link between the GBA gene and parkinsonism
- (2012) Ellen Sidransky et al. LANCET NEUROLOGY
- Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine
- (2012) Santica M. Marcovina et al. Translational Research
- The Microbiome and Butyrate Regulate Energy Metabolism and Autophagy in the Mammalian Colon
- (2011) Dallas R. Donohoe et al. Cell Metabolism
- Neurotoxin-based models of Parkinson's disease
- (2011) J. Bové et al. NEUROSCIENCE
- α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease
- (2010) Nicole M. Gatto et al. NEUROEPIDEMIOLOGY
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- The role of α-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response
- (2009) Mikhail Y. Golovko et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Metabolomic Profiling in LRRK2-Related Parkinson's Disease
- (2009) Krisztina K. Johansen et al. PLoS One
- Metabolomic profiling to develop blood biomarkers for Parkinson's disease
- (2008) M. Bogdanov et al. BRAIN
- Comprehensive analysis ofLRRK2in publicly available Parkinson's disease cases and neurologically normal controls
- (2008) Coro Paisán-Ruíz et al. HUMAN MUTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started